Log In
Print this Print this

SMT C1100 (formerly BMN 195)

Also known as: formerly VOX C1100, VOXC 1100

  Manage Alerts
Collapse Summary General Information
Company Summit Therapeutics plc
DescriptionSmall molecule utrophin up-regulator
Molecular Target Utrophin (UTRN)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation U.S. - Orphan Drug (Treat Duchenne muscular dystrophy (DMD));
EU - Orphan Drug (Treat Duchenne muscular dystrophy (DMD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today